Sex-dependence of synaptic depression induced by activation of metabotropic glutamate receptors in rat hippocampus.
Liam T RalphJohn GeorgiouGraham L CollingridgePatrick TidballPublished in: Brain and neuroscience advances (2024)
The modulation of synaptic efficacy by group I metabotropic glutamate receptors is dysregulated in several neurodevelopmental and neurodegenerative disorders impacting cognitive function. The progression and severity of these and other disorders are affected by biological sex, and differences in metabotropic glutamate receptor signalling have been implicated in this effect. In this study, we have examined whether there are any sex-dependent differences in a form of long-term depression of synaptic responses that is triggered by application of the group I metabotropic glutamate receptor agonist 3,5-dihydroxyphenylglycine (DHPG). We studied DHPG-induced long-term depression at the Schaffer collateral-commissural pathway in area CA1 of hippocampal slices prepared from three separate age groups of Sprague Dawley rats. In both juvenile (2-week-old) and young adult (3-month-old) rats, there were no differences between sexes in the magnitude of long-term depression. However, in older adult (>1-year-old) rats, DHPG-induced long-term depression was greater in males. In contrast, there were no differences between sexes with respect to basal synaptic transmission or paired-pulse facilitation in any age group. The specific enhancement of metabotropic glutamate receptor-dependent long-term depression in older adult males, but not females, reinforces the importance of considering sex as a factor in the study and treatment of brain disorders.
Keyphrases
- depressive symptoms
- sleep quality
- young adults
- prefrontal cortex
- physical activity
- oxidative stress
- magnetic resonance
- blood pressure
- diabetic rats
- multiple sclerosis
- randomized controlled trial
- magnetic resonance imaging
- clinical trial
- middle aged
- drug induced
- brain injury
- blood brain barrier
- endothelial cells
- combination therapy
- double blind